363 related articles for article (PubMed ID: 6288184)
1. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
Heffner TG; Seiden LS
Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
[TBL] [Abstract][Full Text] [Related]
2. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
Miller FE; Heffner TG; Kotake C; Seiden LS
Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
[TBL] [Abstract][Full Text] [Related]
3. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
Castall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
[TBL] [Abstract][Full Text] [Related]
4. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
Finn IB; Iuvone PM; Holtzman SG
Neuropharmacology; 1990 Jul; 29(7):625-31. PubMed ID: 1974712
[TBL] [Abstract][Full Text] [Related]
5. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
Minnema DJ; Rosecrans JA
Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
[TBL] [Abstract][Full Text] [Related]
6. Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment.
Luthman J; Fredriksson A; Lewander T; Jonsson G; Archer T
Psychopharmacology (Berl); 1989; 99(4):550-7. PubMed ID: 2594922
[TBL] [Abstract][Full Text] [Related]
7. Proposed animal model of attention deficit hyperactivity disorder.
Kostrzewa RM; Brus R; Kalbfleisch JH; Perry KW; Fuller RW
Brain Res Bull; 1994; 34(2):161-7. PubMed ID: 7913871
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat.
Erinoff L; MacPhail RC; Heller A; Seiden LS
Brain Res; 1979 Mar; 164():195-205. PubMed ID: 427556
[TBL] [Abstract][Full Text] [Related]
9. Failure of amphetamine isomers to decrease hyperactivity in developing rats.
Concannon JT; Schechter MD
Pharmacol Biochem Behav; 1982 Jul; 17(1):5-9. PubMed ID: 7122666
[TBL] [Abstract][Full Text] [Related]
10. Effects of central dopamine depletion on the d-amphetamine discriminative stimulus in rats.
Woolverton WL; Cervo L
Psychopharmacology (Berl); 1986; 88(2):196-200. PubMed ID: 3006111
[TBL] [Abstract][Full Text] [Related]
11. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
Carter CJ; Pycock CJ
Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants.
Martin-Iverson MT; Leclere JF; Fibiger HC
Eur J Pharmacol; 1983 Oct; 94(3-4):193-201. PubMed ID: 6418553
[TBL] [Abstract][Full Text] [Related]
13. Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine.
Clarke PB; Jakubovic A; Fibiger HC
Psychopharmacology (Berl); 1988; 96(4):511-20. PubMed ID: 3149775
[TBL] [Abstract][Full Text] [Related]
14. Depletion of central catecholamines alters amphetamine- and fenfluramine-induced taste aversions in the rat.
Lorden JF; Callahan M; Dawson R
J Comp Physiol Psychol; 1980 Feb; 94(1):99-114. PubMed ID: 7372855
[TBL] [Abstract][Full Text] [Related]
15. The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat.
Marek GJ; Vosmer G; Seiden LS
Brain Res; 1990 May; 516(1):1-7. PubMed ID: 2142010
[TBL] [Abstract][Full Text] [Related]
16. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
[TBL] [Abstract][Full Text] [Related]
17. Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat.
Archer T; Fredriksson A; Jonsson G; Lewander T; Mohammed AK; Ross SB; Söderberg U
Psychopharmacology (Berl); 1986; 88(2):141-6. PubMed ID: 3081924
[TBL] [Abstract][Full Text] [Related]
18. Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions.
Commins DL; Shaughnessy RA; Axt KJ; Vosmer G; Seiden LS
J Neural Transm; 1989; 77(2-3):197-210. PubMed ID: 2503586
[TBL] [Abstract][Full Text] [Related]
19. Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.
Davids E; Zhang K; Kula NS; Tarazi FI; Baldessarini RJ
J Pharmacol Exp Ther; 2002 Jun; 301(3):1097-102. PubMed ID: 12023542
[TBL] [Abstract][Full Text] [Related]
20. Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OHDA pretreatment.
Bruto V; Beauchamp C; Zacharko RM; Anisman H
Psychopharmacology (Berl); 1984; 83(1):62-9. PubMed ID: 6429702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
